[1]
Chowdhury, K. et al. 2024. A Comparative Study of Safety and Efficacy of Clopidogrel and Prasugrel in Reducing Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention. International Journal of Human and Health Sciences (IJHHS). 8, 4 (Nov. 2024), 328–334. DOI:https://doi.org/10.31344/ijhhs.v8i4.731.